Implications of Ethics Determinant on Dentistry and Pharmacy Research

Sponsor
Misr International University (Other)
Overall Status
Completed
CT.gov ID
NCT05195671
Collaborator
(none)
131
1
2.3
57

Study Details

Study Description

Brief Summary

The ethical review of dental and pharmacy research protocols has its own challenges facing the institutional ethical committees. Seemingly low risk procedure might pose controversies among committees' members. The aim of this article is to describe some of the ethical concerns, particular to dental and pharmacy research that an ethics committee could face while reviewing dental research.

Condition or Disease Intervention/Treatment Phase
  • Other: Review

Detailed Description

The investigators have read all protocols submitted to the MIU IRB and reviewed all meetings' minutes to outline the ethical concerns that warranted discussions in the meetings, and how the committee came to a resolution for those concerns.

Study Design

Study Type:
Observational
Actual Enrollment :
131 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Implications of Ethics Determinant on Dentistry and Pharmacy Research: A Study of IRB Perspective
Actual Study Start Date :
Oct 1, 2021
Actual Primary Completion Date :
Dec 1, 2021
Actual Study Completion Date :
Dec 10, 2021

Outcome Measures

Primary Outcome Measures

  1. Ethical concerns [1 month]

    Frequencies and percentages of ethical concerns

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • all protocols submitted to IRB
Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Misr International University Cairo Egypt

Sponsors and Collaborators

  • Misr International University

Investigators

  • Study Director: Mahassen M Farghaly, Professor, Vice president of community services and environmental awareness

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Misr International University
ClinicalTrials.gov Identifier:
NCT05195671
Other Study ID Numbers:
  • ETH12
First Posted:
Jan 19, 2022
Last Update Posted:
Jan 19, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Misr International University

Study Results

No Results Posted as of Jan 19, 2022